EMN Stock Analysis — Eastman Chemical Company
Sector: Chemicals
AI Verdict
At 10.4x forward earnings and with a moat based on patented processes, EMN is cheap for the growth you're getting if the turnaround materializes — but the market is clearly skeptical after a -16.28% year and negative revenue growth.
Competitive Moat
Eastman Chemical specializes in advanced materials and specialty additives, with a moat built on proprietary chemical processes and long-term customer relationships in industries like automotive and packaging. Its defensibility comes from high switching costs and a portfolio of patented products that competitors can't easily replicate.
Summary
EMN's forward P/E of 10.4x and projected 86.8% EPS growth make it a standout value play in chemicals after a tough year.
Where It Stands
Shares are down -16.28% over the past year with an RSI of 32.6 (oversold) and trade at 10.4x next year's earnings, well below the sector median of 20x.
Key Metrics
- RSI: 32.6 — Near Oversold
- Trailing P/E: 19.4x
- Forward P/E: 10.4x
- PEG Ratio: 0.21
- Earnings Growth: +0.9%
- Revenue Growth: -0.1%
- Market Cap: $8.0B
- Dividend Yield: 0.05%
- 1-Year Return: -16.28%
- 52-Week High: $83.47
- 52-Week Low: $56.11
Analyst Consensus
13 Buy · 9 Hold · 0 Sell (22 analysts)
Bull Case
With analysts expecting 86.8% EPS growth and a forward P/E of just 10.4x, you're getting unusually cheap exposure to a major earnings rebound.
Bear Case
If the P/E reverts to the sector median of 20x only after earnings disappoint, the current 19.4x trailing P/E could compress further, risking more downside from here.
Catalyst to Watch
Watch for the next quarterly earnings — a miss on the expected EPS rebound could snap the oversold RSI and push valuation even lower.